Novavax (NVAX) Q1 2026 Earnings Report
MX:NVAX Q1 2026 EPS Results
- Actual EPS
- -MXN 1.13
- Consensus EPS
- -MXN 4.55
- Beat/Miss
- Beat by +MXN 3.42
- One Year Ago EPS
- MXN 55.06
MX:NVAX Q1 2026 Revenue Results
- Actual Revenue
- MXN 2.62B
- Expected Revenue
- MXN 1.50B
- Beat/Miss
- Beat by +MXN 1.12B
- YoY Revenue Growth
- -79.07%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/06/2026
- Time
- Before Open
- Conference Call
- Wednesday, May 6, 2026
MX:NVAX Upcoming Earnings
Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q1 2026 Earnings Call Audio
MX:NVAX Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NVAX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -6.50- | -23.49 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -7.14-6.01 | 11.65 | -151.61% (-17.66) | |
| May 06, 2026 | 2026 (Q1) | -4.55-1.13 | 55.06 | -102.05% (-56.19) | |
| Feb 26, 2026 | 2025 (Q4) | -9.112.07 | -9.58 | 121.57% (+11.65) | |
| Nov 06, 2025 | 2025 (Q3) | -22.48-23.49 | -14.28 | -64.47% (-9.21) | |
| Aug 06, 2025 | 2025 (Q2) | 0.1511.65 | 18.6 | -37.37% (-6.95) | |
| May 08, 2025 | 2025 (Q1) | -7.9555.06 | -19.73 | 379.05% (+74.79) | |
| Feb 27, 2025 | 2024 (Q4) | -9.66-9.58 | -27.06 | 64.58% (+17.48) | |
| Nov 12, 2024 | 2024 (Q3) | -14.86-14.28 | -23.68 | 39.68% (+9.40) | |
| Aug 08, 2024 | 2024 (Q2) | 31.3818.60 | 10.9 | 70.69% (+7.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
